Schoonderwoerd K, Hom M L, Luthjens L H, Vieira van Bruggen D, Jansen H
Department of Biochemistry, Cardiovascular Research Institute (COEUR), Faculty of Medicine and Health Sciences, Erasmus University Rotterdam, The Netherlands.
Biochem J. 1996 Sep 1;318 ( Pt 2)(Pt 2):463-7. doi: 10.1042/bj3180463.
Lipoprotein lipase (LPL) is functionally active only as a dimer. It is also generally assumed that the highly homologous hepatic lipase functions as a dimer, but no clear evidence has been presented. A hepatic lipase-like activity, also indicated as L-type lipase, is present in adrenal and ovary tissues. This enzyme is thought to originate from the liver and to be identical to hepatic lipase. We determined the functional molecular mass of hepatic lipase in rat liver, adrenal gland and ovary by radiation inactivation, a method for determining the functional size of a protein without the need of prior purification. Samples were exposed to ionizing radiation at -135 degrees C. Hepatic lipase activity in liver homogenate showed a single exponential decay. The functional molecular mass was calculated to be 63 +/- 10 kDa. Hepatic lipase activity in adrenal homogenate was found to have a functional molecular mass of 117 +/- 16 kDa. The functional molecular masses of the lipases partially purified from rat liver perfusate, adrenal homogenate or ovarian homogenate showed the same pattern, a target mass for the liver enzyme of 56 +/- 6 kDa and a target mass of 117 +/- 14 kDa for the enzyme from adrenal gland or ovary. In Western blot analysis the mass of the structural units of hepatic lipase in liver was 57 kDa and in adrenal and ovary tissue 51 kDa. We conclude that the functional unit of hepatic lipase in the liver is a monomer. The enzyme in adrenal gland and ovary is different from the liver and the functional unit may be a dimer.
脂蛋白脂肪酶(LPL)仅作为二聚体时才具有功能活性。通常还认为,高度同源的肝脂肪酶也以二聚体形式发挥作用,但尚未有明确证据。在肾上腺和卵巢组织中存在一种肝脂肪酶样活性,也被称为L型脂肪酶。这种酶被认为起源于肝脏,且与肝脂肪酶相同。我们通过辐射失活法测定了大鼠肝脏、肾上腺和卵巢中肝脂肪酶的功能分子量,这是一种无需事先纯化即可确定蛋白质功能大小的方法。样品在-135℃下接受电离辐射。肝脏匀浆中的肝脂肪酶活性呈现单指数衰减。计算得出功能分子量为63±10 kDa。肾上腺匀浆中的肝脂肪酶活性的功能分子量为117±16 kDa。从大鼠肝脏灌注液、肾上腺匀浆或卵巢匀浆中部分纯化的脂肪酶的功能分子量呈现相同模式,肝脏酶的目标分子量为56±6 kDa,肾上腺或卵巢中的酶的目标分子量为117±14 kDa。在蛋白质印迹分析中,肝脏中肝脂肪酶结构单元的分子量为57 kDa,肾上腺和卵巢组织中的为51 kDa。我们得出结论,肝脏中肝脂肪酶的功能单元是单体。肾上腺和卵巢中的酶与肝脏中的不同,其功能单元可能是二聚体。